Prime Medicine PRME

HealthcareMarket cap $500M1 connection

Prime Medicine uses prime editing - a CRISPR-based technology that can make all 12 types of DNA mutations without double-strand breaks. It's the most versatile gene editing approach yet developed. The technology came from the Broad Institute's David Liu lab. Prime's pipeline targets chronic granulomatous disease and other genetic conditions.

Open Prime Medicine's Company Hub Simulate a merger Supply chain See it on the map

Partners 1

Strategic partnerships, joint products and alliances

Bristol-Myers SquibbHealthcare · $128BPrime Medicine and BMS cell-therapy collaboration (2024)since 2024

Other Healthcare companies

Eli Lilly Johnson & Johnson AbbVie Novo Nordisk Merck UnitedHealth Thermo Fisher AstraZeneca Amgen Novartis

Embed this on your site

Show Prime Medicine's network in an article or report - it updates as our data does.

<iframe src="https://vexmap.com/embed.html?co=PRME" width="600" height="420" style="border:0;border-radius:12px;max-width:100%" title="Prime Medicine on VexMap" loading="lazy"></iframe>

Preview

Relationships are compiled by VexMap from company filings, announcements and reporting, and last reviewed September 2026. Spotted something wrong? Tell us. Not investment advice.